Coronavirus Disease (COVID-19) and SARS-CoV-2
The novel coronavirus belongs to the β genus. COVID-19 is an acute respiratory infectious disease. People are generally susceptible. Currently, the patients infected by the novel coronavirus are the main source of infection; asymptomatic infected people can also be an infectious source. Based on the current epidemiological investigations, the incubation period is 1 to 14 days, mostly 3 to 7 days. The main manifestation include fever, fatigue and dry cough. Nasal congestion, runny nose, sore throat, myalgia and diarrhea are found in a few cases.
The COVID-19 virus spreads primarily through close contact with an infected person (within 6 feet) via droplets of saliva or discharge from the nose or mouth when an infected person coughs or sneezes and inhaled through the nose into the lungs.
SARS-CoV-2 IgG/IgM Antibody Detection Kit
Beroni Group has developed the SARS-CoV-2 IgG/IgM antibody detection kit in response to the current global SARS-CoV-2 crisis. Our detection kit is a rapid in vitro diagnostic based on immunochromatographic detection techniques (lateral flow) developed for the qualitative and differential detection of a patient’s IgG and the IgM antibody to SARS-CoV-2 in human whole blood (including ‘fingerstick’ blood), plasma and serum.
This product can be distributed in the EU, where it has received CE-IVD certification and is currently under EUA review by the FDA.
Advantages of the SARS-CoV-2 IgG/IgM antibody detection kit:
Download the user guide for the SARS-CoV-2 IgG/IgM antibody detection kit.